ATE297193T1 - Parenterales pimaricin zur behandlung von systemischen infektionen - Google Patents

Parenterales pimaricin zur behandlung von systemischen infektionen

Info

Publication number
ATE297193T1
ATE297193T1 AT98939905T AT98939905T ATE297193T1 AT E297193 T1 ATE297193 T1 AT E297193T1 AT 98939905 T AT98939905 T AT 98939905T AT 98939905 T AT98939905 T AT 98939905T AT E297193 T1 ATE297193 T1 AT E297193T1
Authority
AT
Austria
Prior art keywords
composition
pimaricin
pharmaceutically acceptable
mammal
antifungal
Prior art date
Application number
AT98939905T
Other languages
English (en)
Inventor
Borje S Andersson
Elias J Anaissie
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE297193T1 publication Critical patent/ATE297193T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
AT98939905T 1997-08-15 1998-08-07 Parenterales pimaricin zur behandlung von systemischen infektionen ATE297193T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/911,607 US6045815A (en) 1997-08-15 1997-08-15 Parenteral pimaricin as treatment of systemic infections
PCT/US1998/016661 WO1999008663A1 (en) 1997-08-15 1998-08-07 Parenteral pimaricin as treatment of systemic infections

Publications (1)

Publication Number Publication Date
ATE297193T1 true ATE297193T1 (de) 2005-06-15

Family

ID=25430556

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98939905T ATE297193T1 (de) 1997-08-15 1998-08-07 Parenterales pimaricin zur behandlung von systemischen infektionen

Country Status (7)

Country Link
US (3) US6045815A (de)
EP (1) EP1007013B1 (de)
JP (1) JP2001515031A (de)
AT (1) ATE297193T1 (de)
CA (1) CA2295478A1 (de)
DE (1) DE69830496D1 (de)
WO (1) WO1999008663A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
US6291436B1 (en) * 1999-07-16 2001-09-18 International Fiber Corporation Direct action anti-mycotic
WO2003041500A1 (en) * 2001-11-14 2003-05-22 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
CA2519064A1 (en) * 2003-03-21 2004-09-30 Dsm Ip Assets B.V. Stable aqueous solution of a polyene fungicide
US9050317B2 (en) * 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9060926B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US20100111857A1 (en) * 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US9072799B2 (en) * 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9072688B2 (en) * 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US20100111834A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US8731841B2 (en) * 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8731840B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8788211B2 (en) * 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US8762067B2 (en) * 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US8725420B2 (en) * 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20100111841A1 (en) * 2008-10-31 2010-05-06 Searete Llc Compositions and methods for surface abrasion with frozen particles
US8721583B2 (en) * 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8793075B2 (en) * 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8414356B2 (en) 2008-10-31 2013-04-09 The Invention Science Fund I, Llc Systems, devices, and methods for making or administering frozen particles
US9050070B2 (en) * 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9060931B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US20100111835A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US20100111836A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US9050251B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8613937B2 (en) * 2008-10-31 2013-12-24 The Invention Science Fund I, Llc Compositions and methods for biological remodeling with frozen particle compositions
US20100111831A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for surface abrasion with frozen particles
US9060934B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8858912B2 (en) * 2008-10-31 2014-10-14 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate
US8858366B2 (en) 2010-08-20 2014-10-14 Nike, Inc. Golf ball having layers with specified moduli and hardnesses
CN105067734B (zh) * 2015-07-21 2017-05-17 中国农业大学 一种葡萄酒中纳他霉素含量的测定方法
WO2017043972A1 (en) * 2015-09-09 2017-03-16 Arec Crop Protection B.V. An antifungal composition comprising natamycin and c4-c22 fatty acids, monoglycerides of these fatty acids and/or derivatives of these fatty acids
CN113583067B (zh) * 2021-05-31 2023-12-05 华东理工大学 低毒匹马霉素衍生物及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892850A (en) * 1956-03-13 1975-07-01 Gist Brocades Nv Pimaricin and process of producing same
US3343968A (en) * 1965-03-19 1967-09-26 American Cyanamid Co Control of mold growth in eggs
US3343958A (en) * 1965-04-09 1967-09-26 Polaroid Corp Monobath containing cysteine-nitrogenous base combination
ZA742960B (en) * 1973-05-11 1975-08-27 Upjohn Co Stable solutions of pge-type compounds and method of using same
US4148891A (en) * 1974-07-03 1979-04-10 Gist-Brocades N.V. Antifungal preparations
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
DE3036320A1 (de) * 1980-09-26 1982-06-09 Napoleon 6415 Petersberg Papadakis Praeparat zur bekaempfung von fusspilzen
ES504582A0 (es) * 1981-08-06 1982-12-16 Antibioticos Sa Procedimiento de obtencion de antibioticos antifungicos po- lienicos
DE3210138A1 (de) * 1982-03-19 1983-09-22 Röhm Pharma GmbH, 6100 Darmstadt Antimykotische, therapeutische zubereitungen auf creme- und salbenbasis
US4600706A (en) * 1983-11-17 1986-07-15 Carter A F Anti-fungal feed compositions containing natamycin
US4536494A (en) * 1983-11-17 1985-08-20 Carter A Franklin Animal feed method employing natamycin
EP0173729B1 (de) 1984-03-14 1990-10-17 Jérôme CORBIERE Verfahren zum lösen von wirksubstanzen und auf diese weise erhaltene arzneimittel
US4883785A (en) * 1984-07-27 1989-11-28 Chow Wing Sun Complex of anti-fungal agent and cyclodextrin and method
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
US6406713B1 (en) * 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
US5651991A (en) * 1987-10-28 1997-07-29 Nippon Shinyaku Co. Ltd. Drug carriers
US4900775A (en) 1988-02-29 1990-02-13 Gaf Chemicals Corporation Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone
DE3819504A1 (de) 1988-06-08 1989-12-14 Eugen Dr Med Etschenberg Verwendung von pimaricin zur systemischen therapie von infektionen mit plasmodien oder trypanosomen
US4950477A (en) * 1988-08-23 1990-08-21 Memorial Hospital For Cancer And Allied Dieseas Method of preventing and treating pulmonary infection by fungi using aerosolized polyenes
US5277914A (en) * 1989-03-31 1994-01-11 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
EP0664130A1 (de) * 1991-10-25 1995-07-26 Senju Pharmaceutical Co., Ltd. Äusserliche Zubereitung zur Behandlung von Hämorhoidalerkrankungen
EP0608575A1 (de) * 1993-01-27 1994-08-03 Dsm N.V. Vom UV-Licht vernetzte Zusammensetzung ohne Lösungsmittel
ATE311748T1 (de) * 1993-09-29 2005-12-15 Dsm Ip Assets Bv Modifizierte formen des natamycins, verfahren zu ihrer herstellung und sie enthaltende antifungale zusammensetzungen
US5430057A (en) * 1993-09-30 1995-07-04 Board Of Regents, The University Of Texas System Parenteral busulfan for treatment of malignant disease
EP0678241B1 (de) * 1994-04-11 2001-11-07 Dsm N.V. Stabile Natamycin-Suspensionen
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
EP0817620B1 (de) 1995-03-28 2002-01-30 Fidia Advanced Biopolymers, S.R.L. Nanosphären mit einem biokompatiblen polysaccharid
US5877205A (en) * 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
DE69838338T2 (de) * 1997-10-22 2008-05-21 Jens Rochester Ponikau Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
KR100743404B1 (ko) * 2000-12-21 2007-07-30 넥타르 테라퓨틱스 폴리엔 항균제의 폐 전달

Also Published As

Publication number Publication date
EP1007013B1 (de) 2005-06-08
CA2295478A1 (en) 1999-02-25
US20040037907A1 (en) 2004-02-26
US7220726B2 (en) 2007-05-22
EP1007013A1 (de) 2000-06-14
DE69830496D1 (de) 2005-07-14
EP1007013A4 (de) 2001-08-29
US20020155141A1 (en) 2002-10-24
WO1999008663A1 (en) 1999-02-25
JP2001515031A (ja) 2001-09-18
US6045815A (en) 2000-04-04
US7153838B2 (en) 2006-12-26

Similar Documents

Publication Publication Date Title
DE69830496D1 (de) Parenterales pimaricin zur behandlung von systemischen infektionen
NO20000157D0 (no) Sammensetning og fremgangsmåte ved behandling av penil erektil dysfunksjon
ATE423566T1 (de) Augenbehandlung unter verwendung von cyclosporin a derivaten
RU99102246A (ru) Стабильный водный препарат пептидов (варианты), способ его получения (варианты), способ лечения субъекта (варианты)
ATE173603T1 (de) Behandlung von erektionversagen
NO982730L (no) Antagonister av det gonadotropinfrigj°rende hormon
ES2033429T3 (es) Un metodo de preparacion de una composicion farmaceutica.
DE60112102D1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
ATE63220T1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
PT933993E (pt) Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
DE60004793D1 (de) Echinocandin-kohlenhydrate-komplexe
MY137752A (en) Medicament for treating aseptic inflammations containing anemonin as effective component
BG29423A3 (en) Fungicide mans and method for fungus fihting
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
WO1998006265A3 (en) Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
NO832089L (no) Fremgangsmaate ved fremstilling av en terapeutisk virksom metronidazolester
NO20015246L (no) Liposompreparater med forbedret medikamentretensjon
DK1207861T3 (da) Behandling af svampeinfektioner under anvendelse af svampevækstmedium
ATE194492T1 (de) Topische behandlung von blepharitis
IE43886L (en) Antifungal compositions
EP0788799A3 (de) LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen
IE45740L (en) Antihelmintic compositions
ES2180345T3 (es) Nuevo procedimiento para la crio-conservacion de plantas.
NO965591L (no) Kombinasjonsbehandling av HIV-infeksjon
AR005730A1 (es) Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties